{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:41:23Z","timestamp":1768520483575,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cld.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T08:23:56Z","timestamp":1444724636000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"20","author":[{"given":"Souvik","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib2","first-page":"162","article-title":"MRCP vs. ERCP in the evaluation of biliary pathologies: review of current literature","volume":"9","author":"Hekimoglu","year":"2008","journal-title":"J\u00a0Dig Dis"},{"issue":"9","key":"10.1016\/j.cld.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-2008-1077509","article-title":"Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Weber","year":"2008","journal-title":"Endoscopy"},{"issue":"5","key":"10.1016\/j.cld.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","article-title":"Geoepidemiology of primary sclerosing cholangitis: a critical review","volume":"46","author":"Tanaka","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0168-8278(14)60007-6","article-title":"Primary sclerosing cholangitis from a global perspective\u2014a multicenter, retrospective, observational study of the International PSC Study Group","volume":"60","author":"Weism\u00fcller","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4\u00a0and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus","year":"2010","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","article-title":"Prognosis of primary sclerosing cholangitis in Israel is independent of coexisting inflammatory bowel disease","volume":"9","author":"Yanai","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"issue":"6","key":"10.1016\/j.cld.2015.08.005_bib12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2015.08.005_bib14","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12016-010-8221-3","article-title":"Cutting edge issues in primary sclerosing cholangitis","volume":"41","author":"Bowlus","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2015.08.005_bib17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/ard.2007.077826","article-title":"The FCRL3 -169T>C polymorphism is\u00a0associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases","volume":"67","author":"Eike","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1572-0241.2006.00928.x","article-title":"Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis","volume":"102","author":"Karlsen","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.005_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2350-9-81","article-title":"Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients","volume":"9","author":"Gaj","year":"2008","journal-title":"BMC Med Genet"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2015.08.005_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2015.08.005_bib24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2015.08.005_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.13154","article-title":"A\u00a0comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease","volume":"41","author":"Eaton","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.cld.2015.08.005_bib26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.gene.6364377","article-title":"Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"8","author":"Karlsen","year":"2007","journal-title":"Genes Immun"},{"issue":"9","key":"10.1016\/j.cld.2015.08.005_bib28","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bjornsson","year":"2011","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-0030-1256872","article-title":"Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy","volume":"44","author":"Vosskuhl","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.cld.2015.08.005_bib32","doi-asserted-by":"crossref","first-page":"325743","DOI":"10.5402\/2012\/325743","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin-G4: a preliminary study","volume":"2012","author":"Parhizkar","year":"2012","journal-title":"ISRN Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2015.08.005_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2014.06.010","article-title":"The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis","volume":"46","author":"Benito de Valle","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A\u00a0retrospective single-center review of primary sclerosing cholangitis in children","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.08.005_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2015.08.005_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2015.08.005_bib40","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/liv.12492","article-title":"Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease","volume":"34","author":"Naess","year":"2014","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2015.08.005_bib41","first-page":"20","article-title":"Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis","volume":"30","author":"Nakazawa","year":"2005","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/iep.12076","article-title":"Frequency and significance of igg4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis","volume":"95","author":"Fischer","year":"2014","journal-title":"Int J Exp Pathol"},{"issue":"Suppl 18","key":"10.1016\/j.cld.2015.08.005_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","article-title":"Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo clinic's HISORt criteria","volume":"42","author":"Chari","year":"2007","journal-title":"J\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2015.08.005_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis","volume":"43","author":"Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2015.08.005_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","article-title":"Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis","volume":"58","author":"Al Mamari","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2015.08.005_bib46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","article-title":"Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis","volume":"11","author":"Lindstrom","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11\u201312","key":"10.1016\/j.cld.2015.08.005_bib47","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/apt.12979","article-title":"Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis","volume":"40","author":"Rupp","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.27180","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?)","volume":"60","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.005_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611500077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611500077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T20:51:27Z","timestamp":1537303887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932611500077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S108932611500077X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}